Abstract
The IgA glomerulonephritis (IgAGN) is one of the most common primary glomerulonephritis and has a variable and difficult to predict evolution toward the end‐stage nephrosclerosis. The deposition of C3d complement component in peritubular capillaries (PTCs) indicates a variant type of acute rejection while C3d deposition in primary glomerulonephritis (GN) is poorly documented. The aim of this study is to examine C3d expression in peritubular capillaries (PTCs) as a predictive marker and its correlation with the severity of renal injury in IgA glomerulonephritis. Polyclonal FITC conjugated rabbit anti‐human C3c and C3d antibodies were used for direct immunofluorescent evaluation of the C3c and C3d deposits in 24 kidney biopsies with IgA glomerulonephritis. The study revealed that the C3d deposits in peritubular capillaries were associated with known predictors for rapid progression of IgAGN: glomerular sclerosis (63.6%), atrophic tubules (90,9%) and interstitial sclerosis (81,8%). The intensity of the C3c glomerular immunofluorescent deposits was related with active lesions. Thus, the predictive value of C3d deposition on PTCs in IgAGN is worth to be taken into consideration as an unfavorable outcome of the disease and request further long run investigations.
Keywords: IgA glomerulonephritis, complement system ‐peritubular capillaries, C3c, C3d
References
- 1. Roos A., Bouwman L.H., Van Gijlswijk‐Janssen D.J., Faber‐Krol M.C., Stahl G.L., Daha M.R., Human IgA activates the complement system via the mannan‐binding lectin pathway, J. Immunol., 167: 2861–2868, 2001. [DOI] [PubMed] [Google Scholar]
- 2. Lhotta K., Wurzner R., Konig P., Glomerular deposition of mannose‐binding lectin in human glomerulonephritis, Nephrol. Dial. Transplant., 14: 881–886, 1999. [DOI] [PubMed] [Google Scholar]
- 3. Floege J., Feehally J., IgA Nephropathy: Recent Developments, J. Am. Soc. Nephrol., 11: 2395–2403, 2000. [DOI] [PubMed] [Google Scholar]
- 4. Asghar S., Pasch M.C., Complement as a promiscuous signal transduction device, Lab. Invest. 78: 1203–1225, 1998. [PubMed] [Google Scholar]
- 5. Wolbink G.J., Brouwer M.C., Buysmann S., ten Berge I.J.M., Hack C.E., CPR‐mediated Activation of Complement in Vivo, J. Immunol., 157: 473–479, 1996. [PubMed] [Google Scholar]
- 6. Sahu A., Lambris J.D., Structure and biology of the complement protein C3, a connecting link between innate and acquired immunity, Immunol. Rev., 180: 35–48, 2001. [DOI] [PubMed] [Google Scholar]
- 7. Manderson A.P., Pickering M.C., Botto M., Walport M.J., Parish C.R., Continual low‐level activation of the classical complement pathway, J. Exp. Med., 194: 747–756, 2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Sheerin N.S., Sacks S., Complement and complement inhibitors: their role in autoimmune and inflammatory diseases, Curr. Opin. Nephrol. Hypertens., 7: 305–310, 1998. [DOI] [PubMed] [Google Scholar]
- 9. Cosio F.G., Sedmak D.D., Nahman N.S., Localization of decay accelerating factor in normal and diseased kidneys, Kidney Int., 36: 100–107, 1989. [DOI] [PubMed] [Google Scholar]
- 10. Sheerin N.S., Springall T., Abe K., Sacks S., Protection and injury: the differing roles of complement in the development of glomerular injury, Eur. J. Immunol., 31: 1255–1260, 2001. [DOI] [PubMed] [Google Scholar]
- 11. Lesavre P, Monteiro RC, Chevailler A, Berger J, Halbwachs‐Mecarelli L, Noel LH., Recent immunologic data on human glomerulonephritis. Adv. Nephrol. Necker Hosp., 17: 57–75, 1988. [PubMed] [Google Scholar]
- 12. Nakagawa H., Suzuki S., Haneda M., Gejyo F., Kikkawa R., Significance of glomerular deposition of C3c and C3d in IgA nephropathy, Am. J. Nephrol., 20: 122–128, 2000. [DOI] [PubMed] [Google Scholar]
- 13. Muso E., Sekita K., Doi T., Kuwahara T., Yoshida H., Tamura T., Kawai C., Hamashima Y., Immunopathological correlation between mesangial C3d‐deposition and C3d‐fixing circulating immune complexes in lupus nephritis, Clin. Immunol. Immunopathol., 32: 351–358, 1984. [DOI] [PubMed] [Google Scholar]
- 14. Kuypers D.R., Lerut E., Evenepoel P., Maes B., Vanrenterghem Y., Van Damme B., C3d deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome, Transplantation, 76: 102–108, 2003. [DOI] [PubMed] [Google Scholar]
- 15. Droz D. La biopsie rénale dans les glomérulonéphrites à dépots mésangiaux d'IgA: maladie de Berger et purpura rhumatoïde In: Droz D., Lantz B. La biopsie rénale. INSERM; / Paris , 1996, pp. 161–163. [Google Scholar]
- 16. Radford M.G. Jr., Donadio J.V. Jr., Bergstralh E.J., Grande J.P., Predicting renal outcome in IgA nephropathy, J. Am. Soc. Nephrol., 8: 199–207, 1997. [DOI] [PubMed] [Google Scholar]
- 17. Schulze M., Pruchno C.J., Burns M., Baker P.J., Johnson R.J., Couser W.G., Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis, Am. J. Pathol., 142: 179–187, 1993. [PMC free article] [PubMed] [Google Scholar]
- 18. Hautanen A., Keski‐Oja J., Interaction of fibronectin with complement component C3, Scand. J. Immunol., 17: 225–230, 1983. [DOI] [PubMed] [Google Scholar]
- 19. Leivo I., Engvall E., C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast, J. Cell. Biol., 103: 1091–1100, 1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Johnson E., Gauperaa T., Eskeland T., Fibronectin binds to complement‐coated agarose beads and increases their association to mouse macrophages, Scand. J. Immunol., 22: 315–20, 1985. [DOI] [PubMed] [Google Scholar]
- 21. Welch T.R., Beischel L.S., Witte D.P., Differential expression of complement C3 and C4 in the human kidney, J. Clin. Invest., 92: 1451–1458, 1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Welch T.R., Frenzke M., Witte D., Evidence of a role for local complement expression in a murine model of progressive glomerulonephritis, Pediatr. Res., 48: 200–205, 2000. [DOI] [PubMed] [Google Scholar]
- 23. Sacks S., Zhou W., Sheerin N.S., Complement synthesis in the injured kidney: does it have a role in immune complex glomerulonephritis?, J. Am. Soc. Nephrol., 7: 2314–2319, 1996. [DOI] [PubMed] [Google Scholar]
- 24. Tang S., Zhou W., Sheerin N.S., Vaughan R.W., Sacks S.H., Contribution of renal secreted complement C3 to the circulating pool in humans, J. Immunol., 162: 4336–4341, 1999. [PubMed] [Google Scholar]
- 25. Sacks S., Zhou W., The effect of locally synthesized complement on acute renal allograft rejection, Mol. Med., 81: 404–410, 2003. [DOI] [PubMed] [Google Scholar]
- 26. Dempsey P.W., Dempsey P.W., Allison M.D., Akkaraju S., Goodnow C., Fearon D.T., C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity, Science, 271: 348–350, 1996. [DOI] [PubMed] [Google Scholar]
- 27. Carroll M.C., The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol., 16: 545–568, 1998. [DOI] [PubMed] [Google Scholar]
- 28. Bennett M., Leanderson T., Was it there all the time?, Scand. J. Immunol., 57: 499–505, 2003. [DOI] [PubMed] [Google Scholar]
- 29. Sohn J.H., Bora P., Suk H.J., Molina H., Kaplan H.J., Bora N., Tolerance is dependent on complement C3 fragment iC3b binding to antigen‐presenting cells, Nature Medicine, 9: 206–212, 2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Mandache E., Gherghiceanu M., Ultrastructural defects of the glomerular basement membranes associated with primary glomerular nephropathies, Ultrastructural Pathology, 2: 103–108, 2004. [DOI] [PubMed] [Google Scholar]